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Introduction
　Organ-specific autoimmune diseases are character-
ized by tissue destruction and functional decline due 
to autoreactive T cells that escape self-tolerance1,2. 
Sj o¨  gren's syndrome（SS）is a T cell-mediated autoim-
mune disorder characterized by lymphocytic infiltrates 
and destruction of the salivary and lacrimal glands, 
and systemic production of autoantibodies to the 
ribonucleoprotein（RNP）particles SS-A/Ro and SS-
B/La3,4.  Autoreactive T cells bearing the CD4 molecule 
may recognize an unknown autoantigen triggering 
autoimmunity in the salivary and lacrimal glands, 
leading to clinical symptoms of dryness of the mouth 
and eyes（sicca syndrome） 5,6.  Although it has been 
argued that T cells play an important role in the 
development of organ-specific autoimmune disease, it is 
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not known whether disease is initiated by a restrained 
inflammatory reaction to an organ-specific autoantigen. 
In most cases, antigenic challenge results in the 
establishment of immunological memory, a state in 
which the immune system is maintained to respond 
effectively upon recurrent antigenic exposure.  It is now 
evident that the interaction of Fas with FasL regulates 
a large number of pathophysiological processes of 
apoptosis including autoimmune diseases7,8.  Recent 
studies have now confirmed the observation that 
apoptotic cells in various cell types are implicated as 
the source of autoantigen when stimulated with 
different proapoptotic stimuli9―11.  Apoptosis results in 
surface accessibility of all SSA/Ro-SSB/La antigens 
for recognition by circulating maternal antibodies. 
Although cleavage of certain autoantigens during 
apoptosis may reveal immunocryptic epitopes that 
could potentially induce autoimmune responses in 
systemic autoimmune diseases12,13, accumulated evi-
dence suggests an important role of apoptosis in the 
disease pathogenesis of Sj o¨  gren's syndrome14.
Apoptotic cells in target organs
　Recent studies have suggested that the Fas-FasL 
system plays a major role in the induction of apoptosis 
in target organs with autoimmune diseases such as 
autoimmune gastritis, Hashimoto's thyroiditis, and 
rheumatoid arthritis（RA） 15―17.  It has been reported 
that both Fas and FasL are present in thyrocytes and 
their concomitant expression on thyrocytes, independ-
ent of infiltrating T cells, is responsible for thyrocyte 
destruction in Hashimoto's thyroiditis18.  In contrast, 
expression of Fas by pancreaticβ cells has been shown 
to have a major influence on the susceptibility of 
tissue destruction in nonobese diabetic（NOD）mice to 
diabetes19,20.  Since it was reported that Fas expression 
was observed in the salivary gland cells with human 
Sj o¨  gren's syndrome21, it is likely that Fas-mediated 
apoptosis contributes to tissue destruction in the 
salivary glands with Sj o¨  gren's syndrome.  A cleavage 
product of 120 kDa α -fodrin was identified as an 
important autoantigen in human Sj o¨  gren's syndrome 
besides the NFS/sld murine model for Sj o¨  gren's 
syndrome22.  Alpha-fodrin is a ubiquitous, calmodulin-
binding protein found to be cleaved by calcium-
activated protease（calpain）in apoptotic T cells, and by 
calpain and/or caspases 3 in anti-Fas-stimulated Jurkat 
cells and/or neuronal apoptosis23―26.  It was demon-
strated that the fodrin α subunit is cleaved in 
association with apoptosis, and the 120 kDa fragment is 
a breakdown product of the mature form of 240 kDa 
fodrin α subunit27.  Previous studies have revealed 
evidence that caspase 3 is required for α -fodrin 
cleavage during apoptosis28.  In Jurkat cells, caspase 3-
like proteases have been reported to cleaveα -fodrin and 
poly（ADP-ribose）polymerase（PARP） 29.  In neuroblas-
toma cells, treatment with staurosporin induced 
cleavage of α -fodrin at both caspase 3 and calpain 
cleavage sites30.  In vitro studies demonstrated that 
apoptotic mouse salivary gland（MSG）cells result in a 
specificα -fodrin cleavage into 120 kDa, and preincuba-
tion with caspase-inhibitor peptides blocked α -fodrin 
cleavage31.  A significant increase of TUNEL ＋-apoptotic 
epithelial duct cells in the salivary glands was detected 
in NFS/sld  Sj o¨  gren's syndrome mouse model（Fig. 1） . 
Tissue-infiltrating CD4 ＋ T cells isolated from the 
salivary gland tissues bear a large proportion of FasL
（Fig. 2A & 2B） , and MSG cells constitutively express 
Fas with high proportion.  Anti-Fas mAb-stimulated 
apoptosis in MSG cells was confirmed by flow cytometry 
of the DNA content of nuclei with PI and Annexin V. 
Western blot analysis demonstrated that the 240 kDa 
 α -fodrin in apoptotic MSG cells was cleaved to smaller 
fragments into 120 kDa in a time-dependent manner, 
and the cleavage was entirely blocked by preincubation 
with caspase inhibitors（z-VAD-fmk, DEVD-CHO）（Fig. 
2C） .  Importantly, the tissue-infiltrating CD4 ＋ T cells, 
but not CD8 ＋ T cells, are responsible for tissue 
destruction as judged by in vitro 51Cr release cytotoxic 
assay against MSG cells in vitro.  Although it has been 
reported that Fas-induced apoptosis seems to be the 
major killing pathway of the CD4 ＋ cytotoxic T cells32, 
one mechanism by which activated CD4 ＋ T cells induce 
cytotoxicity towards salivary gland cells in Sj o¨  gren's 
syndrome is Fas-based.  In vivo treatment with caspase-
inhibitors, z-VAD-fmk and DEVD-CHO, into the murine 
model results in dramatically inhibited development of 
autoimmune lesions, and in restoration of sicca 
syndrome31.  There is increasing evidence that the 
cascade of caspases is a critical component of the cell 
death pathway33―35, and a few proteins have been found 
to be cleaved during apoptosis.  These include poly
（ADP-ribose）polymerase（PARP） , a small U1 nuclear 
ribonucleoprotein（RNP） , and α -fodrin, which were 
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subsequently identified as substrates for caspases36―38. 
The development of autoimmune exocrinopathy in 
Sj o¨  gren's syndrome appears to be dependent on 
autoantigen cleavage through the caspase cascade, and 
caspase-inhibitors might provide a new therapeutic 
option directed at reducing tissue damage.
Activation-induced cell death（AICD）in Sj o¨  gren's 
syndrome
　Activation-induced cell death（AICD）is a well-known 
mechanism of peripheral T cell tolerance that depends 
upon an interaction between Fas and Fas ligand 
（FasL） 39,40.  AICD plays a central role, especially in 
killing autoreactive T cells and in preventing auto- 
immune responses41―43.  It has been reported that 
activation of T cell clones, or T cell lines, induces FasL 
expression, and AICD in T cells in vivo has been 
proposed to limit the expansion of an immune response 
by eliminating effector cells that are no longer needed44. 
Although it is considered that a defect in AICD of 
effector T cells may result in the development of 
autoimmune disease45, the in vivo role of organ-specific 
autoantigen for AICD is entirely unknown.  Since the 
administration of a soluble form of anti-FasL antibody
（FLIM58）results in severe destructive autoimmune 
exocrinopathy in the murine model of Sj o¨  gren's 
syndrome46, it is possible that an organ-specific 
autoantigen plays an important role in the down-
regulation of AICD.  A high titer of serum auto- 
antibodies against 120 kDa α -fodrin autoantigen was 
detected in FLIM58-treated mice, and splenic T cell 
culture supernatants contained high levels of IFN- γ . 
FasL-mediated AICD is down-regulated by autoantigen 
stimulation in spleen cells from the murine model 
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Fig. 1　Tissue-specific apoptosis in the salivary glands in Sj o¨  gren's syndrome mouse 
model31.（A）In situ TUNEL detection was frequently positive for epithelial duct cells 
in 3d-Tx NFS/sld mice（12-wk-old）（A） , but not in non-Tx NFS/sld mice（12-wk-old）
（B） .（C）A significant increase of apoptotic duct cells was observed in the salivary 
gland tissues from 3d-Tx NFS/sld mice at all ages. The percentage of duct cells 
staining positively with TUNEL was enumerated using a 10 × 20 grid net 
micrometer disc, covering an objective of area 0.16 mm2. Data were analyzed in 10 
fields per section, and were expressed as mean percentage± SD in 5 mice examined 
per group（asterisks ＊ , P<0.01 & asterisks ＊＊ , P<0.001, Student's t-test） . Five mice in 
each group were analyzed at 8, 12 and 16 weeks old.  
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Fig. 2　FasL and Fas expression on tissue-infiltrating cells in the salivary gland 
tissues from 3d-Tx NFS/sld mice31.（A）Immunohistochemical detection of 
infiltrating lymphocytes strongly positive for FasL in 3d-Tx NFS/sld mice. 
Epithelial duct cells were stained positively with Fas in 3d-Tx NFS/sld 
mice.（B）Flow cytometric analysis of FasL expression on tissue-infiltrating 
lymphocytes isolated from salivary glands of 3d-Tx NFS/sld mice gated on 
CD4 and CD8. FasL expression on tissue-infiltrating CD4 ＋ T cells was 
prominent compared with that on CD8 ＋ T cells.（C）Western blot analysis 
demonstrated that the 240 kDa α -fodrin in apoptotic MSG cells was 
cleaved to smaller fragments into 120 kDa in a time-dependent manner, 
and the cleavage product was entirely blocked by preincubation with 
caspase inhibitors（z-VAD-fmk, DEVD-CHO）measured at 24 h. Protease 
inhibitor cocktails, cysteine protease inhibitor（E64） , and serine protease 
inhibitor（Leupeptin）had no significant effect onα -fodrin cleavage. The 
MSG cell apoptosis induced by anti-Fas mAb（Jo2）stimulation was 
determined by flow cytometry of the DNA content of nuclei with PI and 
Annexin V.
of Sj o¨  gren's syndrome, but not from Fas-deficient 
MRL/lpr mice and FasL-deficient MRL/gld mice.  FasL 
undergoes metalloproteinase（MMP） -mediated prote-
olytic processing in its extracellular domains, resulting 
in the release of soluble trimeric ligands（soluble FasL, 
sFasL） .  In this case, the processing of sFasL occurs in 
autoantigen-specific CD4 ＋ T cells, and a significant 
increase in expressions of MMP-9 mRNA was observed 
in spleen cells from the mouse model of Sj o¨  gren's 
syndrome46.  In vitro T cell apoptosis assay indicated 
that FasL-mediated AICD is down-regulated by auto- 
antigen stimulation in the murine SS model.  The data 
indicate that the increased generation of soluble FasL 
inhibits the normal AICD process, leading to the 
proliferation of effector CD4 ＋ T cells46.  Our study 
demonstrates that an organ-specific autoantigen may 
play an important role in the down-modulation of FasL-
mediated AICD.  The increased generation of sFasL 
inhibits the normal AICD process, leading to the 
proliferation of effector CD4 ＋ T cells in the murine SS 
model.  Previous studies have demonstrated that CD4 ＋ 
T cells are susceptible to AICD induced through TCR-
mediated recognition of allogeneic MHC class II 
molecules, supporting the notion that AICD can be 
triggered in activated T cells through the TCR-
mediated recognition of antigen47―49.  Mice or human 
individuals lacking functional Fas or FasL display 
profound lymphoproliferative reactions associated with 
autoimmune disorders7,50.  In proteoglycan-induced 
arthritis, CD4 ＋ T cells proliferate at a high rate in 
response to proteoglycan stimulation, and exhibit a 
Th1-type response51.  The study investigated whether 
when Th1 cells were dominant, disease outcome could 
be modified with pharmacological amounts of Th2 
cytokines.  Treatment with IL-4 prevented disease and 
induced a switch from a Th1-type to a Th2-type 
response.  Proinflammatory cytokine mRNA transcripts 
were reduced in joints of cytokine-treated mice.  Th2 
cytokine therapy at the time of maximum joint 
inflammation also suppressed symptoms of disease. 
These observations have suggested that a defect in 
AICD of autoreactive Th1 cells may contribute to the 
pathogenesis of Sj o¨  gren's syndrome. CD4 ＋ T cells are 
susceptible to AICD induced through TCR-mediated 
recognition of allogeneic MHC class II molecules52,53. 
Our data demonstrated that autoantigen stimulation 
results in a significant decrease in anti-Fas-induced 
CD4 ＋ T cell apoptosis in a dose-dependent manner.  In 
addition, AICD is triggered in CD4 ＋ T cells by a specific 
antigenic peptide, e.g. tetanus toxoid or myelin basic 
protein, presented by the appropriate MHC class II 
molecules（54） , supporting the notion that AICD can be 
triggered in activated cells through the TCR-mediated 
recognition of antigen.  The specificity of cytotoxic T 
lymphocyte（CTL）function has been an important issue 
of organ-specific autoimmune response, but little is 
known about the events triggering T cell invasion of the 
target organs as a prelude to organ-specific autoim-
mune diseases.
Tissue-specific  apoptosis induced by estrogen 
deficiency
　Recently, we have evaluated the effects on autoanti-
gen cleavage in estrogen deficient healthy C57BL/6（B6）
mice treated with an ovariectomy（Ovx）（Fig. 3A） .  We 
have demonstrated a significant apoptosis associated 
with α -fodrin cleavage in the salivary gland cells of 
estrogen deficient healthy C56BL/6（B6）mice55（Fig. 
3B） .  These data suggest that α -fodrin cleavage 
triggered by estrogen deficiency plays a role in the 
development of autoimmune exocrinopathy in the 
salivary and lacrimal glands.  In contrast, apoptotic 
cells in the salivary glands were not found in ER α KO 
mice.  In in vitro studies using primary cultured mouse 
salivary gland cells（MSG）and human salivary gland 
cells（HSG） , we found a cleavage product of 120 kDa 
 α -fodrin in cells that had undergone tamoxifen（Tam） -
induced apoptosis, but not in other types of cells 
including MCF-7.  Since pretreatment with estrogen 
inhibits the Tam-induced apoptosis of MSG and HSG 
cells, estrogen may play a crucial role in the apoptosis-
related signal pathway.  When we analyzed whether 
cystein proteases are involved in Tam-induced apopto-
sis of HSG cells, we observed a time-dependent increase 
in the active forms of caspase 1.  In addition, we found 
that the promoter activity of caspase 1 was significantly 
increased when HSG cells transfected with the 
promoter-caspase 1 gene were stimulated with Tam. 
Indeed, active forms of caspase 1 were detected only in 
the salivary gland tissues from Ovx-B6 mice.  Of 
importance is that adoptive transfer of α -fodrin-
reactive T cells into Ovx-B6 mice resulted in the 
development of autoimmune exocrinopathy similar to 
SS.  It has been strongly suggested that α -fodrin 
59November, 2004 TLRs in Cancer Immunotherapy
fragments induced by estrogen deficiency may play an 
important role in the development of autoimmune 
lesions in Sj o¨  gren's syndrome55.  We have demonstrated 
that antiestrogenic actions, including estrogen defi-
ciency, may have a crucial influence on apoptosis and 
 α -fodrin proteolysis through an increased caspase 
activity in the salivary gland cells, suggesting a novel 
mechanism for the development of organ-specific 
autoimmunity in postmenopausal women.  Molecular 
mechanisms responsible for tissue-specific apoptosis 
induced by estrogen deficiency are now being investi- 
gated.
Apoptosis in labial gland biopsies with Sj o¨  gren's 
syndrome
　To evaluate tissue-specific apoptosis and autoantigen 
cleavage in the salivary glands with Sj o¨  gren's syn- 
drome, we analyzed human biopsy specimens by 
immunohistology and immunoblotting.  All patients 
with SS were female, had documented xerostomia and 
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Fig. 3　Tissue-specific apoptosis in the salivary glands induced by estrogen 
deficiency55.（A）Detection of TUNEL ＋-apoptotic cells in the salivary gland 
sections from Ovx- and Sham-C57BL/6（B6）mice at 3 weeks after Ovx
（arrows） . Annexin V-flow cytometric analysis using MSG cells 
demonstrated 12.5%-positive cells detected in Ovx-B6 mice, but 3.1%-
positive in Sham-B6 mice. Data are represented in triplicate.（B）Detection 
of α -fodrin cleavage in various tissues from Ovx- and Sham-B6 mice on 
Western blot analysis showing the distinct band of 120 kDa in the salivary 
gland tissue alone from Ovx-B6 mice.
keratoconjunctivitis sicca, and fulfilled the San Diego 
criteria for the diagnosis of Sj o¨  gren's syndrome. 
Analyses were performed under the certification of 
the ethics board of Tokushima University Hospital. 
Immunofluorescence analysis using polyclonal Ab 
against synthetic 120 kDaα -fodrin demonstrated that a 
cleavage product of α -fodrin was present in epithelial 
duct cells of the labial salivary gland biopsies from SS 
patients, but not in control glands（Fig. 4A & 4B） . 
Western blot analysis confirmed the same results, 
indicating that a cleavage product of 120 kDa α -fodrin 
is present in the diseased glands with Sj o¨  gren's 
syndrome.  Immunohistochemical analysis revealed 
that a majority of infiltrating cells were CD4 ＋ , and that 
a small number of CD8 ＋ cells were present in the 
salivary glands with Sj o¨  gren's syndrome.  Immunofluo-
rescence analysis revealed that a large number of 
infiltrating lymphoid cells bear FasL in the salivary 
glands with Sj o¨  gen's syndrome（Fig. 4C） , and epithelial 
duct cells stained positively with Fas on their cell 
surface（Fig. 4D） .  Thus, we provided evidence 
suggesting that Fas/FasL-mediated apoptosis may be 
involved in in vivo cleavage of α -fodrin autoantigen in 
the salivary glands with Sj o¨  gren's syndrome.
On the horizon
　A cleavage product of 120 kDaα -fodrin was identified 
as an important organ-specific autoantigen in human 
Sj o¨  gren's syndrome.  The data discussed in this review 
are strongly suggestive of the essential role of caspase 
cascade for α -fodrin autoantigen cleavage leading to 
tissue destruction in autoimmune exocrinopathy in 
Sj o¨  gren's syndrome.  Alpha-fodrin cleavage by caspases 
can potentially lead to cytoskeletal rearrangement, and 
it is of interest to point out that α -fodrin binds to 
ankylin, which contains a cell death domain56.  It has 
been shown that cleavage products of α -fodrin inhibit 
ATP-dependent glutamate and γ -aminobutyric acid 
accumulation into synaptic vesicles57, suggesting that a 
cleavage product of 120 kDa α -fodrin could be a novel 
component of unknown immunoregulatory networks 
such as cytolinker proteins58.  In vitro T cell apoptosis 
assay indicated that FasL-mediated AICD is down-
regulated by autoantigen stimulation in spleen cells 
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Fig. 4　Immunohistological features in the labial gland biopsies with Sj o¨  gren's 
syndrome.（A）A cleavage product of 120 kDa α -fodrin was present 
exclusively in epithelial duct cells of the SS salivary glands with Sj o¨  gren's 
syndrome, but not in（B）control salivary glands with mucous cyst.（C）
Immunofluorescence analysis revealed that the majority of tissue-
infiltrating lymphoid cells bore FasL, and（D）epithelial duct cells stained 
positively with Fas on their cell surface in SS salivary glands with Sj o¨  gren's 
syndrome. Six samples for each were examined.
from murine Sj o¨  gren's syndrome.  The processing of 
sFasL occurs in autoantigen-specific CD4 ＋ T cells in 
vivo, and a significant increase in expressions of MMP-9 
mRNA was observed in spleen cells from the mouse 
model.  These data indicate that the increased 
generation of sFasL inhibits the normal AICD process, 
leading to the proliferation of effector CD4 ＋ T cells.  We 
have recently observed that CD4 ＋ T cells freshly 
isolated from PBMC with SS patients induce Th1 
cytokine（IL-2, IFN- γ ） , suggesting that the autoantigen 
peptide plays an important role in the Th1/Th2 balance 
in vivo. Moreover,α -fodrin peptide-pulsed CD4 ＋ T cells 
down-regulate Fas-mediated apoptosis when pulsed 
with each corresponding peptide.  Although antigen-
induced T cell death is known to be regulated by CD4 
expression, molecular mechanisms responsible for T 
cell death should be further elucidated.  However, 
it remains unclear whether T cells specific for 
endogenous epitopes play a significant pathologic role 
in tissue damage during clinical episodes.  Our data 
demonstrated that AFN peptide-stimulation results in 
a significant decrease in anti-Fas-induced CD4 ＋ T cell 
apoptosis.  120 kDa α -fodrin, the apoptosis associated 
breakdown product, may play an important role in the 
development of SS, and that the autoantigen peptide is 
a novel participant in the down-modulation of Th1/Th2 
balance and peripheral T cell tolerance.  It is a future 
possibility that a peptide analogue of autoantigen could 
be used as an immunotherapeutic agent.
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